Trial information
A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.
Status: Recruiting
Protocol number: DECREASE-VI
Company division: Diagnostic
Official Scientific Title: A prospective study to assess the screening value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for the identification of patients that benefit from additional cardiac testing prior to vascular surgery.
Brief summary: The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.
Study type: Interventional; Non-Randomized; Open Label; Historical; Parallel study
Condition: Peripheral Vascular Disease
Intervention type: Diagnostic Test
Intervention name: ELECSYS®proBNP
Inclusion criteria:
- adult patients, ≥18 years of age;
- patients with peripheral vascular atherosclerosis, scheduled for vascular surgery.
Exclusion criteria:
Gender: Males or Females
Age limits: Min: 18 Years Max: N/A (No limit)
Accepts healthy volunteers: No
Anticipated start date: February, 2007
Trial registration date: 08/21/2007
Date last updated: 11/21/2008
Link to trial result
This trial is being conducted at the following locations:
Belgium
Brazil
France
Ireland
Italy
Netherlands
- Arnhem
- Beverwijk
- Heerlen
- Hoogeveen
- Nieuwegein
- Nijmegen
- Rotterdam
- Zwolle
Poland
Serbia and Montenegro
